We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Moderna Inc | NASDAQ:MRNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-4.87 | -3.90% | 120.13 | 120.10 | 120.19 | 125.15 | 118.75 | 125.00 | 2,221,341 | 17:13:33 |
By Will Feuer
Moderna Inc. is creating a new role on its executive committee as it prepares for the launch of multiple new products after the success of its Covid-19 vaccine.
The biotechnology company said Juan Andres, chief technical operations and quality officer, will step into a new role as president of strategic partnerships and enterprise expansion, effective Jan. 1. He will continue to serve on the executive committee and report to Chief Executive Stephane Bancel.
In his new role, Mr. Andres will focus on building out the company to support its growing pipeline, Moderna said.
Moderna said it will hire Jerh Collins, an executive at Novartis AG, to succeed Mr. Andres. Mr. Collins will join Moderna on Oct. 3 and will assume the role of chief technical operations and quality officer on Jan. 1, the company said. He will also serve on the executive committee and report to Mr. Bancel.
"I am very pleased that Juan will apply his leadership and experience to allow Moderna to scale in its next phase of growth. Juan's continued leadership will be critical as we prepare for several upcoming new product launches," Mr. Bancel said.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
September 29, 2022 08:31 ET (12:31 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Moderna Chart |
1 Month Moderna Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions